+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Copovidone Market - Global Forecast 2026-2032- Product Image
Copovidone Market - Global Forecast 2026-2032- Product Image
Sale

Copovidone Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6157858
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Copovidone: Role in Modern Pharmaceutical Formulation

Copovidone is a water-soluble vinylpyrrolidone-vinyl acetate copolymer used primarily as a pharmaceutical excipient. Its functional profile supports applications such as binding in solid oral dosage forms, film formation, solubility enhancement, and stabilization of active ingredients. Demand is shaped by formulation complexity, regulatory expectations for excipient quality, and continued development of generic, branded-generic, and specialty medicines.

Formulation Complexity Is Reshaping Copovidone Demand

Pharmaceutical developers are increasingly balancing manufacturability, dissolution performance, stability, and patient-use requirements. These priorities are encouraging broader evaluation of multifunctional excipients that can support efficient processing while addressing poorly soluble or moisture-sensitive active ingredients. At the same time, tighter documentation, supply qualification, and change-control expectations are making consistency of quality and traceability more important across the excipient supply chain.

Artificial Intelligence Accelerates Formulation Screening and Quality Control

Artificial intelligence is influencing copovidone-related development indirectly through faster formulation design, process optimization, and analytical interpretation. Machine-learning tools can help researchers compare excipient combinations, identify relationships between material attributes and dissolution behavior, and prioritize laboratory experiments. In manufacturing and quality operations, AI may support anomaly detection, predictive maintenance, document review, and trend analysis, although human oversight, validated models, data integrity, and regulatory acceptance remain essential.

Regional Dynamics Reflect Diverse Pharmaceutical Manufacturing Priorities

North America emphasizes stringent quality systems, complex drug-delivery development, and reliable excipient qualification. Latin America is supported by expanding pharmaceutical production and the need for dependable formulation inputs, with regulatory harmonization and import continuity remaining important. Europe combines mature pharmaceutical manufacturing with strong expectations for documentation, sustainability, and supply-chain transparency. The Middle East is strengthening local healthcare and pharmaceutical capabilities, increasing attention to qualified materials and dependable sourcing. Africa presents varied development conditions, where access, local manufacturing ambitions, and regulatory capacity shape excipient adoption. Asia-Pacific remains central to pharmaceutical production and formulation activity, with demand influenced by manufacturing scale, domestic medicine access, and evolving regulatory systems.

Economic and Regulatory Groups Shape Common Excipient Priorities

ASEAN markets are linked by regional manufacturing networks while retaining differing regulatory and procurement requirements. BRICS economies combine substantial pharmaceutical demand with efforts to strengthen domestic production and supply resilience. The European Union places strong emphasis on harmonized quality, sustainability, and compliance expectations. G7 members generally apply advanced pharmaceutical quality systems and encourage innovation in complex formulations. GCC countries are investing in healthcare capacity and pharmaceutical localization, increasing the importance of qualified supply partners. NATO members span diverse pharmaceutical markets, but many share heightened attention to continuity planning, strategic materials, and resilient healthcare supply chains.

Country-Level Signals Highlight Varied Formulation and Supply Priorities

Australia combines a regulated medicines environment with reliance on dependable international supply networks. Brazil’s pharmaceutical sector is shaped by domestic production, regulatory oversight, and access priorities. Canada supports advanced pharmaceutical development while maintaining rigorous quality expectations. China has a large and increasingly sophisticated pharmaceutical manufacturing base, with continuing attention to quality modernization and supply security. France, Germany, Italy, and Spain reflect Europe’s mature formulation capabilities and detailed compliance requirements. India combines extensive generic-drug manufacturing with growing interest in complex formulations and domestic supply resilience. Japan emphasizes high standards for quality, process control, and product consistency. Mexico connects regional manufacturing with pharmaceutical import and distribution networks. Russia’s pharmaceutical landscape is influenced by localization and supply-continuity priorities. South Korea is recognized for advanced biopharmaceutical and pharmaceutical manufacturing capabilities. The United Kingdom maintains strong regulatory and research infrastructure, while the United States remains a major center for innovative formulation development, stringent excipient qualification, and advanced manufacturing practices.

Build Resilience Through Qualification, Technical Collaboration, and Data Discipline

Industry leaders should qualify multiple dependable sources where feasible, establish clear material-attribute specifications, and maintain robust change-control procedures. Development teams can improve outcomes by evaluating copovidone alongside active ingredients, manufacturing processes, packaging systems, and intended release profiles rather than treating it as an isolated input. Companies should strengthen supplier audits, traceability, regulatory documentation, and contingency planning. AI-enabled screening and quality analytics should be introduced through controlled, validated workflows with expert review. Sustainability assessments, regional regulatory mapping, and early engagement with contract manufacturers can further reduce development and commercialization friction.

Methodology: Evidence-Based Review of Formulation, Regulation, and Supply Factors

This executive summary applies a structured qualitative assessment of copovidone’s pharmaceutical role, considering its established excipient functions, formulation-development needs, manufacturing practices, regulatory expectations, and regional supply-chain conditions. Insights are organized across the specified regions, economic and political groups, and countries. The analysis excludes market estimates, market sizing, market shares, forecasts, and company-specific claims, and focuses on verifiable industry characteristics rather than unsupported numerical conclusions.

Copovidone Remains a Strategic Excipient for Reliable Drug Development

Copovidone’s combination of binding, film-forming, solubility-supporting, and stabilizing properties keeps it relevant to pharmaceutical formulation work. Its future importance will depend less on a single application than on developers’ ability to integrate excipient performance with process robustness, regulatory compliance, supply continuity, and data-driven development. Organizations that combine disciplined qualification with formulation expertise and carefully governed digital tools will be better positioned to manage increasingly complex medicine-development requirements.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Copovidone Market, by Formulation Techniques
8.1. Introduction
8.2. Direct Compression
8.2.1. Innovative Tablet Design
8.3. Film Coating
8.3.1. Taste Masking Applications
8.4. Hot Melt Extrusion
8.4.1. Enhanced Solubility Methods
9. Copovidone Market, by Functional Applications
9.1. Introduction
9.2. Adhesive Binder
9.2.1. Tablet Binders
9.3. Film Former
9.3.1. Oral Films
9.4. Solubilizer
9.4.1. Improved Bioavailability
10. Copovidone Market, by Product Types
10.1. Introduction
10.2. Granules
10.3. Oral Film Dosage
10.3.1. Thin Films
10.4. Oral Solid Dosage
10.4.1. Capsules
10.4.2. Tablets
11. Copovidone Market, by Innovative Technologies
11.1. Introduction
11.2. 3D Printing In Pharmaceuticals
11.2.1. Personalized Medicine
11.3. Nanotechnology Enabled Systems
11.3.1. Targeted Delivery
12. Americas Copovidone Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Copovidone Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Copovidone Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ashland Global Holdings Inc.
15.3.2. BASF SE
15.3.3. ChemPol Solutions
15.3.4. Clariant AG
15.3.5. Cognis Corporation
15.3.6. Colorcon, Inc.
15.3.7. Dow Chemical Company
15.3.8. DPI Corporation
15.3.9. DuoPharma International
15.3.10. Eastman Chemical Company
15.3.11. Evonik Industries AG
15.3.12. Excipio Technologies
15.3.13. Fagron NV
15.3.14. Global Excipients Group
15.3.15. InterExcipients Corporation
15.3.16. JRS Pharma Limited
15.3.17. Lonza Group AG
15.3.18. Lubrizol Corporation
15.3.19. LUCI Pharma Inc.
15.3.20. MedChemEx Industries
15.3.21. Mitsubishi Chemical Corporation
15.3.22. NexGen Polymers LLC
15.3.23. NovaChem Excipients Ltd.
15.3.24. PharmaPolymer Solutions Inc.
15.3.25. PolyMerex Inc.
15.3.26. Polysciences, Inc.
15.3.27. PrimePoly Inc.
15.3.28. Roquette Frères
15.3.29. Solvay S.A.
15.3.30. TriMed Solutions
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COPOVIDONE MARKET MULTI-CURRENCY
FIGURE 2. COPOVIDONE MARKET MULTI-LANGUAGE
FIGURE 3. COPOVIDONE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COPOVIDONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COPOVIDONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COPOVIDONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COPOVIDONE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COPOVIDONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COPOVIDONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COPOVIDONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TABLET DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COPOVIDONE MARKET SIZE, BY FILM COATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COPOVIDONE MARKET SIZE, BY TASTE MASKING APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COPOVIDONE MARKET SIZE, BY ENHANCED SOLUBILITY METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COPOVIDONE MARKET SIZE, BY TABLET BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COPOVIDONE MARKET SIZE, BY FILM FORMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COPOVIDONE MARKET SIZE, BY IMPROVED BIOAVAILABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COPOVIDONE MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COPOVIDONE MARKET SIZE, BY THIN FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COPOVIDONE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COPOVIDONE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COPOVIDONE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COPOVIDONE MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. CANADA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 86. CANADA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 87. CANADA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 88. CANADA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 89. CANADA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. CANADA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 91. CANADA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 92. CANADA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 93. CANADA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 94. CANADA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 95. CANADA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 96. CANADA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 97. CANADA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 98. CANADA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 102. MEXICO COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 111. MEXICO COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. CHINA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 158. CHINA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 159. CHINA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 160. CHINA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 161. CHINA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. CHINA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 163. CHINA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 164. CHINA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 165. CHINA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 166. CHINA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 167. CHINA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 168. CHINA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 169. CHINA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. CHINA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. INDIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 172. INDIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 173. INDIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 174. INDIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 175. INDIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. INDIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 177. INDIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 178. INDIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 179. INDIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 180. INDIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 181. INDIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 182. INDIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 183. INDIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 184. INDIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. JAPAN COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. JAPAN COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 201. JAPAN COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 202. JAPAN COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 203. JAPAN COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 204. JAPAN COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 205. JAPAN COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 206. JAPAN COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 207. JAPAN COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 208. JAPAN COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 209. JAPAN COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 210. JAPAN COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 211. JAPAN COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 212. JAPAN COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 284. THAILAND COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 285. THAILAND COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 286. THAILAND COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 289. THAILAND COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 291. THAILAND COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 292. THAILAND COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 293. THAILAND COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 295. THAILAND COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 296. THAILAND COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 326. DENMARK COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 327. DENMARK COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 328. DENMARK COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 329. DENMARK COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 330. DENMARK COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 331. DENMARK COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 332. DENMARK COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 333. DENMARK COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 334. DENMARK COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 335. DENMARK COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 336. DENMARK COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 337. DENMARK COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 338. DENMARK COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 339. DENMARK COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 340. EGYPT COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 341. EGYPT COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 342. EGYPT COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 343. EGYPT COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 344. EGYPT COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 345. EGYPT COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 346. EGYPT COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 347. EGYPT COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 348. EGYPT COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 349. EGYPT COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 350. EGYPT COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 351. EGYPT COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 352. EGYPT COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 353. EGYPT COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 354. FINLAND COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 355. FINLAND COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 356. FINLAND COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 357. FINLAND COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030

Companies Mentioned

  • Ashland Global Holdings Inc.
  • BASF SE
  • Celanese Corporation
  • Clariant AG
  • Colorcon, Inc.
  • Croda International Plc
  • Daicel Corporation
  • Dow Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Huntsman Corporation
  • JRS Pharma GmbH & Co. KG
  • Kuraray Co., Ltd.
  • Lubrizol Corporation
  • LyondellBasell Industries N.V.
  • Merck KGaA
  • Mitsui Chemicals, Inc.
  • Polysciences, Inc.
  • Roquette Frères
  • Sekisui Chemical Co., Ltd.
  • Shinobi Pharma Inc.
  • Shin‑Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • Sumitomo Chemical Company, Limited
  • Wacker Chemie AG

Related Topics

Related Reports

Copovidone (PVP-VA) Global Market Report 2026 - Product Image

Copovidone (PVP-VA) Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sustained Release Excipients Market Report 2026 - Product Image

Sustained Release Excipients Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Pharmaceutical Lubricant Excipients Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Lubricant Excipients Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Pharmaceutical Carbohydrate Excipients Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Carbohydrate Excipients Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Excipients - Global Strategic Business Report - Product Image

Excipients - Global Strategic Business Report

  • Report
  • 254 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.